Kai Lin

Years Active: 2022-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ashleigh Shannon, Véronique Fattorini, Bhawna Sama, Barbara Selisko, Mikael Feracci, Camille Falcou, Pierre Gauffre, Priscila El Kazzi, Adrien Delpal, Etienne Decroly, Karine Alvarez, Cécilia Eydoux, Jean-Claude Guillemot, Adel Moussa, Steven S Good, Paolo La Colla, Kai Lin, Jean-Pierre Sommadossi, Yingxiao Zhu, Xiaodong Yan, Hui Shi, François P Ferron, Bruno Canard
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase. Nature communications 13 (1) (2022)
Fabien Zoulim, Adam Zlotnick, Stephanie Buchholz, Eric Donaldson, John Fry, Anuj Gaggar, Jianming Hu, Michael Kann, Oliver Lenz, Kai Lin, Nagraj Mani, Michael Nassal, William Delaney, Su Wang, Gabriel Westman, Veronica Miller, Harry L A Janssen
Nomenclature of HBV core protein-targeting antivirals. Nature reviews. Gastroenterology & hepatology 19 (12) (2022)
Kai Lin, Steven S Good, Justin G Julander, Abbie E Weight, Adel Moussa, Jean-Pierre Sommadossi
AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model. PLoS neglected tropical diseases 16 (1) (2022)

Kai Lin.css-eqlu8i{font-size:small;padding-left:4px;}